Medi-Physics, Inc

Zealand Pharma is a leading biotechnology company specializing in the development of next-generation peptide therapeutics for various diseases, including obesity and rare conditions. With a strong focus on research and development, Zealand Pharma is committed to inventing novel therapies using their peptide platform to address unmet medical needs. Driven by a mission to change lives, Zealand Pharma is advancing clinical pipeline programs and conducting phase 3 clinical trials to investigate the efficacy of their peptide-based candidates for people living with obesity and overweight. With a dedication to specialty disease areas, Zealand Pharma aims to bring innovative solutions to patients worldwide.Generated from the website

Blue Oak Pharmaceuticals Inc is a pioneering biopharmaceutical company based in Concord, MA, dedicated to revolutionizing the treatment of brain disorders. With a focus on developing first-in-class and best-in-class drugs, their breakthrough approach challenges the traditional target-based methods used by the industry, offering new hope to millions of patients and their families who suffer from mental illness. By utilizing an unbiased approach to systems neuroscience and leveraging their privileged chemistry platform, Blue Oak is able to examine the entire brain circuitry and identify drug-like compounds with high efficiency. Their innovative use of predictive AI design, in collaboration with partners Exscientia and PsychoGenics, optimizes small molecules to normalize the behavioral symptoms of brain disorders. With a robust pipeline of clinical programs targeting bipolar depression, treatment-resistant depression, schizophrenia, and geriatric psychosis, Blue Oak is at the forefront of transforming the CNS drug discovery paradigm.Generated from the website